Want numbers on formulary pain? Sanofi’s diabetes sales are Exhibit A

As payers increasingly look to put a lid on drug costs—partly through formulary management—the decision by two leading pharmacy benefit managers to exclude Sanofi's big-sellers in diabetes took a toll in 2017.Original Article